Results 221 to 230 of about 108,085 (245)
What's New? This study is the first to quantify the cost‐effectiveness of breast cancer treatment in German Cancer Society‐certified hospitals using real‐world data from over 140,000 patients. Analysis on certification‐related costs and survival outcomes demonstrates that high‐quality multidisciplinary care at certified hospitals delivers substantial ...
Min‐Wai Lwin +20 more
wiley +1 more source
Artificial intelligence in obstetrics and gynecology: Evaluating ChatGPT and Google Gemini in answering patient questions. [PDF]
West M +6 more
europepmc +1 more source
What's New? The CDK4/6 inhibitor ribociclib in combination with an endocrine‐based therapy has demonstrated significant progression‐free and overall survival benefits in patients with advanced/metastatic HR+/HER2‐ breast cancer in the pivotal MONALEESA trials.
Peter A. Fasching +20 more
wiley +1 more source
Education, Pregnancy Status, and Diet Adherence in Gestational Diabetes: Perceived Burden of Dietary Management. [PDF]
Tomczewska K +5 more
europepmc +1 more source
What's New? Epithelial ovarian cancer (EOC) is a severe malignancy with few effective treatment options. While the mechanisms remain unclear, changes in lipid metabolism may fuel tumor growth and EOC progression, offering a possible path for new treatments.
Hitomi Sakaguchi‐Mukaida +10 more
wiley +1 more source
Causal Relationship Between Sex Hormone Binding Globulin and Obstetrical Disorders: A Two-Sample Bidirectional Mendelian Randomization Study. [PDF]
Gan Y, Tan X, Tang Y, Shi Q, Qi H.
europepmc +1 more source
Defining “Medical Care”: The Key to Proper Application of the Medical Expense Deduction [PDF]
Ichel, David W.
core +1 more source
What's New? While treatment strategies for solid brain metastases have been relatively uniform across cancer subtypes, tailored approaches are warranted. In this observational study, intracranial recurrences after microsurgical resection occurred significantly earlier and more frequently at distant sites in patients with triple‐negative breast cancer ...
Jonathan Weller +14 more
wiley +1 more source

